Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
Clinical trial NCT02749708 · TERMINATED
Trial details
- NCT number
- NCT02749708
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-30
- Primary completion
- 2018-08-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.